申请人:Revolution Medicines, Inc.
公开号:US20210094975A1
公开(公告)日:2021-04-01
The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.